GTL-001

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameGTL-001
Drug Alias NameProCervixHPV 16E7 HPV 18E7 protein vaccineHPV 16E7-HPV 18E7CyAa-HPV-16E7 CyaA-HPV-18E7 vaccineGTL-001
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCD4-positive T-lymphocytes stimulantsCD8-positive T-Lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus InfectionsReproductive Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenticel Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenticel Sa
Active IndicationsN/A
Inactive IndicationsPapillomavirus InfectionsReproductive Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A